Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alvotech (ALVO) EBT (2021 - 2025)

Alvotech filings provide 5 years of EBT readings, the most recent being $309.5 million for Q4 2025.

  • On a quarterly basis, EBT rose 242.24% to $309.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $136.3 million, a 134.9% increase, with the full-year FY2025 number at $136.3 million, up 162.67% from a year prior.
  • EBT hit $309.5 million in Q4 2025 for Alvotech, up from -$275.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $327.9 million in Q2 2025 to a low of -$651.0 million in Q4 2023.
  • Median EBT over the past 5 years was -$121.4 million (2022), compared with a mean of -$110.2 million.
  • The widest YoY moves for EBT: up 321.33% in 2025, down 99900.0% in 2025.
  • Alvotech's EBT stood at $254.0 million in 2021, then tumbled by 317.17% to -$551.6 million in 2022, then dropped by 18.02% to -$651.0 million in 2023, then soared by 66.58% to -$217.6 million in 2024, then skyrocketed by 242.24% to $309.5 million in 2025.
  • The last three reported values for EBT were $309.5 million (Q4 2025), -$275.9 million (Q3 2025), and $327.9 million (Q2 2025) per Business Quant data.